Aleksandra Palacz-Mielczarek

Sosnowiec, OP 41200, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Selected Chemokines as Prognostic Biomarkers and Therapeutic Targets in Ovarian Cancer.

Selected Chemokines as Prognostic Biomarkers and Therapeutic Targets in Ovarian Cancer.

Journal: Current issues in molecular biology
Published: May 06, 2026

Synthesis and application of quercetin hybrids as potential anticancer agents in the treatment of ovarian cancer.

Synthesis and application of quercetin hybrids as potential anticancer agents in the treatment of ovarian cancer.

Journal: Scientific reports
Published: January 13, 2026

Disorder of the immune and inflammatory response involving galectin-1, -3 and -7 in women with invasive breast cancer - potential importance in diagnosis and monitoring the course of the disease.

Disorder of the immune and inflammatory response involving galectin-1, -3 and -7 in women with invasive breast cancer - potential importance in diagnosis and monitoring the course of the disease.

Journal: Frontiers in oncology
Published: December 22, 2025

Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell-Cycle Control and Tumor Microenvironment Reprogramming.

Ganodermanontriol and Lanostane Triterpenoid Derivatives in Cancer Cell Biology: Signaling Network Modulation, Cell-Cycle Control and Tumor Microenvironment Reprogramming.

Journal: Cell biology international
Published: December 22, 2025

The potential clinical significance of immunomodulation of immune and inflammatory responses involving selected adipokines in patients with ovarian cancer - preliminary studies.

The potential clinical significance of immunomodulation of immune and inflammatory responses involving selected adipokines in patients with ovarian cancer - preliminary studies.

Journal: Frontiers in oncology
Published: November 30, 2025

Dysregulation of adipokines in the serum of breast cancer patients - role in pathogenesis and potential clinical application (preliminary studies).

Dysregulation of adipokines in the serum of breast cancer patients - role in pathogenesis and potential clinical application (preliminary studies).

Journal: Frontiers in immunology
Published: October 14, 2025

NETs - as predictors and targets of supportive therapy for cancer treatment.

NETs - as predictors and targets of supportive therapy for cancer treatment.

Journal: Frontiers in immunology
Published: July 15, 2025

Interleukin 1 family dysregulation in serum and peritoneal fluid of ovarian cancer patients - potential clinical implications.

Interleukin 1 family dysregulation in serum and peritoneal fluid of ovarian cancer patients - potential clinical implications.

Journal: Frontiers in oncology
Published: June 24, 2025

The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis.

The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis.

Journal: Journal of cancer research and clinical oncology
Published: June 05, 2025

Serum Levels of IL-21 and IL-22 in Breast Cancer Patients-A Preliminary Study.

Serum Levels of IL-21 and IL-22 in Breast Cancer Patients-A Preliminary Study.

Journal: Current issues in molecular biology
Published: May 20, 2025

The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).

The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).

Journal: Diagnostics (Basel, Switzerland)
Published: April 17, 2025

Neutrophil extracellular traps in diseases of the female reproductive organs.

Neutrophil extracellular traps in diseases of the female reproductive organs.

Journal: Frontiers in immunology
Published: March 07, 2025
Showing 1-12 of 53

Last Updated: 09/26/2026